Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of ...

A key goal of President Biden’s Inflation Reduction Act was to lower drug prices for seniors. That would have been readily ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

Less than two years ago, neighbors near Brush Creek Boulevard and Troost Avenue had choices when they needed to pick up a ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed ... United States — argued that ...

The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...

The drug middlemen rigged their formularies, steering patients to higher priced insulin when cheaper alternatives were readily available. The result of PBM efforts to maximize profits through rebates ...

Related FDA approves FluMist for upcoming flu season FTC sues prescription drug middlemen, alleging they conspired over high ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The vice president has campaigned on holding big business accountable but has privately sought advice from CEOs and investors ...